Insights from a Phase II Clinical Trial with CL2020 Muse Cell-Based Therapeutic for Amyotrophic lateral sclerosis
Release Subtitle:
A clinical trial evaluated the favorable safety profile of Muse cell-based product, CL2020, in treating patients with Amyotrophi...